This is not a replacement for trials, but it can move much faster, and that speed matters when a drug goes from niche to mainstream almost overnight. A major challenge in this process, which Guntuku calls computational social listening, has been scale
The enforcement scale is real: more than 455 FDA adverse-event reports tied to compounded semaglutide, over 50 warning letters to compounded GLP-1 sellers in 2025, and 30-plus more in March 2026, several of them naming the compounding pharmacies behind telehealth brands
Whether you hit a plateau, never responded at all, or quit because of side effects, you will find specific, actionable guidance here
Proper administration of semaglutide is a key component of its effectiveness for weight loss and diabetes management